欢迎访问《标记免疫分析与临床》官方网站!
方法研究

胶体金法药物滥用检测试剂临床研究要点

展开
  • 国家食品药品监督管理局医疗器械技术审评中心,北京 100044

收稿日期: 2013-11-25

  修回日期: 2013-12-20

  网络出版日期: 2014-07-15

Clinical Trail of Drug Abuse Detection by Colloidal Gold Method

Expand
  • Medical Device Evaluation Center, State of the Food and Drug Administration, Beijing 100044, China

Received date: 2013-11-25

  Revised date: 2013-12-20

  Online published: 2014-07-15

摘要

目的 结合体外诊断试剂现行法规和药物滥用检测试剂自身的特点,阐述其临床研究要点。方法 对该类试剂管理分类、研究方法、临床试验方案设置、临床试验样本选择、结果的统计学分析以及临床试验报告撰写等方面进行了详细解析。结果 确立了体外诊断试剂和药物滥用检测试剂的研究方法。结论 体外诊断试剂和药物滥用检测试剂的临床研究应从试剂本身的临床预期用途出发,重点针对试剂定性的准确性、特异性进行科学的临床考察。

本文引用格式

吕允凤,陈亭亭 . 胶体金法药物滥用检测试剂临床研究要点[J]. 标记免疫分析与临床, 2014 , 21(3) : 303 . DOI: 10.11748/bjmy.issn.1006-1703.2014.03.026

Abstract

Objective To discuss the main points of clinical trails of drug abuse detection reagents. Methods Considering both the active regulations of IVD and the drug abuse detection reagents own characteristics, the characteristics of clinical trails of the drug abuse detection reagents were described in detail. Results Significant problems have been settled such as classification, study method, clinical trail scheme setup, sample selection, statistical analysis of results and reports composing. Conclusion Clinical trails of drug abuse detection reagents should be carried out scientifically and focus on the accuracy and specificity,based on the active regulations and it’s own clinical use.
Options
文章导航

/